S'abonner

Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study - 05/09/22

Doi : 10.1016/j.rmed.2022.106924 
Lei Liu a, b, c, 1, Xin Zhang a, b, c, 1, Li Zhang a, b, c, 1, Ying Liu a, b, c, Hong Ping Zhang a, Shu Zhen Zhao d, Jie Zhang e, Wei Jie Zhang f, Fang Wang g, Lei Wang a, Anny Xiaobo Zhou h, Wei Min Li b, , Gang Wang b, c, , Peter Gerard Gibson i
a Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China 
b Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China 
c Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, 610041, Sichuan, China 
d Outpatient Department, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China 
e Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Jilin University, Changchun 130041, Jilin, China 
f Department of Respiratory Disease, Jilin Province People's Hospital, Changchun, 130021, Jilin, China 
g Department of Pathogen Biology, Basic Medical College, Jilin University, Changchun, 130021, Jilin, China 
h Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA 
i Priority Research Centre for Healthy Lungs and Centre of Excellence in Severe Asthma, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia 

Corresponding author. Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.Department of Respiratory and Critical Care MedicineClinical Research Center for Respiratory DiseaseWest China HospitalSichuan UniversityChengduSichuan610041China∗∗Corresponding author.

Abstract

Background

Given that airway obstruction in asthma is not always fully reversible, reduced bronchodilator reversibility (BDR) may be a special asthma phenotype.

Objective

To explore the characteristics of BDRhigh/low phenotypes (defined using two BDR criteria) and their associations with asthma exacerbations (AEs).

Methods

After baseline assessments, all patients were classified into BDRhigh or BDRlow phenotypes. This study consisted of 2 parts. Part I was a 12-month prospective observational cohort study designed to identify the clinical characteristics and associations with future AEs in BDRhigh/low phenotypes (n = 456). Part II, designed as a post hoc analysis of the data obtained in Part I, was conducted to assess the association between BDRhigh/low phenotypes and treatment responsiveness (n = 360).

Results

Subjects with BDRlow phenotypes had better baseline asthma symptom control and was negatively associated with eosinophilic asthma and type 2 (T2) high asthma. During the 12-month follow-up, those with BDRlow phenotypes had a higher risk of severe AEs (SAEs) (guideline-based criterion: RRadj = 2.24, 95% CI = [1.25, 3.68]; Ward's criterion: RRadj = 2.46, 95% CI = [1.40, 4.00]) and moderate-to-severe AEs (MSAEs) (guideline-based criterion: RRadj = 1.83, 95% CI = [1.22, 2.56]; Ward's criterion: RRadj = 1.94, 95% CI = [1.32, 2.68]) in the following year according to logistic regression models. Similar findings were obtained with negative binominal regression models. BDRlow phenotype was a risk factor for an insensitive response to anti-asthma treatment (guideline-based criterion: ORadj = 1.96, 95% CI = [1.05, 3.65]; Ward's criterion: ORadj = 2.01, 95% CI = [1.12, 3.58]).

Conclusion

We identified that BDRlow phenotype was associated with non-T2 high asthma and future AEs. These findings have clinically relevant implications for asthma management.

Le texte complet de cet article est disponible en PDF.

Highlights

Airway obstruction in asthma is not always fully reversible.
•Bronchodilator reversibility may be a phenotypic marker.
•Reduced bronchodilator reversibility was associated with non-type 2 high asthma.
•Reduced bronchodilator reversibility was related to increased risk of future exacerbations.

Le texte complet de cet article est disponible en PDF.

Keywords : Asthma, Bronchodilator reversibility, Phenotypes, Exacerbations


Plan


© 2022  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 200

Article 106924- août 2022 Retour au numéro
Article précédent Article précédent
  • Antimycobacterial prophylaxis regarding Bacillus Calmette-Guérin -associated complications in children with primary immunodeficiency
  • Beste Ozsezen, Ebru Yalçın, Dilber Ademhan Tural, Birce Sunman, Halime Nayır Buyuksahin, İsmail Guzelkas, Didem Alboga, Elif Soyak Aytekin, Saliha Esenboga, Nagehan Emiralioglu, Deniz Cagdas, Deniz Doğru, Uğur Özçelik, Ilhan Tezcan, Nural Kiper
| Article suivant Article suivant
  • Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
  • Rod Hughes, Eleni Rapsomaniki, Christer Janson, Christina Keen, Barry J. Make, Pierre-Régis Burgel, Erin L. Tomaszewski, Hana Müllerová, Helen K. Reddel, NOVELTY study investigators, Gabriel Benhabib, Xavier Bocca Ruiz, Ricardo del Olmo, Raul Eduardo Lisanti, Gustavo Marino, Walter Mattarucco, Juan Nogueira, Maria Parody, Pablo Pascale, Pablo Rodriguez, Damian Silva, Graciela Svetliza, Carlos F. Victorio, Roxana Willigs Rolon, Anahi Yañez, Stuart Baines, Simon Bowler, Peter Bremner, Sheetal Bull, Patrick Carroll, Mariam Chaalan, Claude Farah, Gary Hammerschlag, Kerry Hancock, Zinta Harrington, Gregory Katsoulotos, Joshua Kim, David Langton, Donald Lee, Matthew Peters, Lakshman Prassad, Helen Reddel, Dimitar Sajkov, Francis Santiago, Frederick Graham Simpson, Sze Tai, Paul Thomas, Peter Wark, José Eduardo Delfini Cançado, Thúlio Cunha, Marina Lima, Alexandre Pinto Cardoso, Marcelo Rabahi, Syed Anees, John Bertley, Alan Bell, Amarjit Cheema, Guy Chouinard, Michael Csanadi, Anil Dhar, Ripple Dhillon, J. Mark FitzGerald, David Kanawaty, Allan Kelly, William Killorn, Daniel Landry, Robert Luton, Piushkumar Mandhane, Andrew McIvor, Bonavuth Pek, Robert Petrella, Daniel Stollery, Meihua Chen, Yan Chen, Wei Gu, Kim Ming Christopher Hui, Manxiang Li, Shiyue Li, Ma Lijun, Guangyue Qin, Weidong Song, Wei Tan, Yijun Tang, Chen Wang, Tan Wang, Fuqiang Wen, Feng Wu, PingChao Xiang, Zuke Xiao, Shengdao Xiong, Jinghua Yang, Jingping Yang, Caiqing Zhang, Min Zhang, Ping Zhang, Wei Zhang, Xiaohe Zheng, Dan Zhu, Fabio Bolivar Grimaldos, Alejandra Cañas Arboleda, Carlos Matiz Bueno, Dora Molina de Salazar, Elisabeth Bendstrup, Ole Hilberg, Carsten Kjellerup, Ulla Weinreich, Philippe Bonniaud, Olivier Brun, Pierre-Régis Burgel, Christos Chouaid, Francis Couturaud, Jacques de Blic, Didier Debieuvre, Dominique Delsart, Axelle Demaegdt, Pascal Demoly, Antoine Deschildre, Gilles Devouassoux, Carole Egron, Lionel Falchero, François Goupil, Romain Kessler, Pascal Le Roux, Pascal Mabire, Guillaume Mahay, Stéphanie Martinez, Boris Melloni, Laurent Moreau, Chantal Raherison, Emilie Riviere, Pauline Roux-Claudé, Michel Soulier, Guillaume Vignal, Azzedine Yaici, Sven Philip Aries, Robert Bals, Ekkehard Beck, Andreas Deimling, Jan Feimer, Vera Grimm-Sachs, Gesine Groth, Felix Herth, Gerhard Hoheisel, Frank Kanniess, Thomas Lienert, Silke Mronga, Jörg Reinhardt, Christian Schlenska, Christoph Stolpe, Ishak Teber, Hartmut Timmermann, Thomas Ulrich, Peter Velling, Sabina Wehgartner-Winkler, Juergen Welling, Ernst-Joachim Winkelmann, Carlo Barbetta, Fulvio Braido, Vittorio Cardaci, Enrico Maria Clini, Maria Teresa Costantino, Giuseppina Cuttitta, Mario di Gioacchino, Alessandro Fois, Maria Pia Foschino-Barbaro, Enrico Gammeri, Riccardo Inchingolo, Federico Lavorini, Antonio Molino, Eleonora Nucera, Alberto Papi, Vincenzo Patella, Alberto Pesci, Fabio Ricciardolo, Paola Rogliani, Riccardo Sarzani, Carlo Vancheri, Rigoletta Vincenti, Takeo Endo, Masaki Fujita, Yu Hara, Takahiko Horiguchi, Keita Hosoi, Yumiko Ide, Minehiko Inomata, Hiromasa Inoue, Koji Inoue, Sumito Inoue, Motokazu Kato, Masayuki Kawasaki, Tomotaka Kawayama, Toshiyuki Kita, Kanako Kobayashi, Hiroshi Koto, Koichi Nishi, Junpei Saito, Yasuo Shimizu, Toshihiro Shirai, Naruhiko Sugihara, Ken-ichi Takahashi, Hiroyuki Tashimo, Keisuke Tomii, Takashi Yamada, Masaru Yanai, Ruth Cerino Javier, Alfredo Domínguez Peregrina, Marco Fernández Corzo, Efraín Montano Gonzalez, Alejandra Ramírez-Venegas, Adrian Rendon, Willem Boersma, R.S. Djamin, Michiel Eijsvogel, Frits Franssen, Martijn Goosens, Lidwien Graat-Verboom, Johannes in 't Veen, Rob Janssen, Kim Kuppens, Maarten van den Berge, Mario van de Ven, Ole Petter Brunstad, Gunnar Einvik, Kristian Jong Høines, Alamdar Khusrawi, Torbjorn Oien, Yoon-Seok Chang, Young Joo Cho, Yong Il Hwang, Woo Jin Kim, Young-Il Koh, Byung-Jae Lee, Kwan-Ho Lee, Sang-Pyo Lee, Yong Chul Lee, Seong Yong Lim, Kyung Hun Min, Yeon-Mok Oh, Choon-Sik Park, Hae-Sim Park, Heung-Woo Park, Chin Kook Rhee, Ho Joo Yoon, Hyoung-Kyu Yoon, Alvar Agusti García-Navarro, Rubén Andújar, Laura Anoro, María Buendía García, Paloma Campo Mozo, Sergio Campos, Francisco Casas Maldonado, Manuel Castilla Martínez, Carolina Cisneros Serrano, Lorena Comeche Casanova, Dolores Corbacho, Felix Del Campo Matías, Jose Echave-Sustaeta, Gloria Francisco Corral, Pedro Gamboa Setién, Marta García Clemente, Ignacio García Núñez, Jose García Robaina, Mercedes García Salmones, Jose Maria Marín Trigo, Marta Nuñez Fernandez, Sara Nuñez Palomo, José Olaguibel Rivera, Luis Pérez de Llano, Ana Pueyo Bastida, Ana Rañó, José Rodríguez González-Moro, Albert Roger Reig, José Velasco Garrido, Dan Curiac, Christer Janson, Cornelia Lif-Tiberg, Anders Luts, Lennart Råhlen, Stefan Rustscheff, Frances Adams, Drew Bradman, Emma Broughton, John Cosgrove, Patrick Flood-Page, Elizabeth Fuller, Timothy Harrison, David Hartley, Keith Hattotuwa, Gareth Jones, Keir Lewis, Lorcan McGarvey, Alyn Morice, Preeti Pandya, Manish Patel, Kay Roy, Ramamurthy Sathyamurthy, Swaminathan Thiagarajan, Alice Turner, Jorgen Vestbo, Wisia Wedzicha, Tom Wilkinson, Pete Wilson, Lo’Ay Al-Asadi, James Anholm, Frank Averill, Sandeep Bansal, Alan Baptist, Colin Campbell, Michael A. Campos, Bradley Chipps, Gretchen Crook, Samuel DeLeon, Alain Eid, Ellen Epstein, Stephen Fritz, Hoadley Harris, Mitzie Hewitt, Fernando Holguin, Golda Hudes, Richard Jackson, Alan Kaufman, David Kaufman, Ari Klapholz, Harshavardhan Krishna, Daria Lee, Robert Lin, Diego Maselli-Caceres, Vinay Mehta, James N. Moy, Ugo Nwokoro, Purvi Parikh, Sudhir Parikh, Frank Perrino, James Ruhlmann, Catherine Sassoon, Russell A. Settipane, Daniel Sousa, Peruvemba Sriram, Richard Wachs

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.